From GlobeNewswire:

Neumora Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The webcast will be available on the company’s website. Neumora is a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases. The company’s pipeline consists of seven neuroscience programs targeting neuropsychiatric disorders and neurodegenerative diseases. For more information, contact Helen Rubinstein at 315-382-3979 or [email protected].



Read more: Neumora Therapeutics to Present at 42nd Annual J.P. Morgan